Table 2 Adverse cardiovascular events in the study population during follow-up
Variable | Total (n=1340) | T1 (n=447) | T2 (n=447) | T3 (n=446) | P value |
|---|---|---|---|---|---|
MACE, n (%) | 217(16.2) | 84(18.8) | 83(18.3) | 51(11.4) | 0.004 |
All-cause death, n (%) | 94(7.0) | 45(10.1) | 37(8.3) | 12(2.7) | < 0.001 |
Cardiac death, n (%) | 54(4.0) | 23(5.1) | 26(5.8) | 5(1.1) | < 0.001 |
Non-fatal MI, n (%) | 36(2.7) | 13(2.9) | 14(3.1) | 9(2.0) | 0.553 |
Unplanned revascularization, n (%) | 119(8.9) | 35(7.8) | 47(10.5) | 37(8.3) | 0.321 |